Genomic Information Management System

Added: Aug 09, 2013 3:30 pm

The U.S. Food and Drug Administration (FDA), Division of Microbiology (DM) at College Park, MD has need of a Genomic Information Management System (GIMS) to: Maintain sample-related metadata for sequences generated, Automate the monitoring of samples as they proceed through workflows, Track sequencing reagents and supplies, Track sequence data, run-related metadata, and sequence analysis metrics while correlating it back to individual samples, and Prepare and convert (as needed) the sample and sequence-related metadata for input into downstream applications such as CLC Bio and submission to NCBI. The location is College Park, Maryland. The start date of performance is to be determined, but will be on or before 09/30/2013.

This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This synopsis is to notify contractors that the government intends to issue a purchase order in accordance with FAR Subpart 13.5 for the following, under simplified acquisition procedures. The request for quote number is FDA‐SOL‐131119904. This is a Request for Quotes. Provisions and clauses in effect through Federal Acquisition Circular 05‐69 are incorporated into this request. It is the contractor's responsibility to be familiar with the applicable clauses and provisions. The provisions and clauses may be accessed in full text at www.acquisition.gov/far. The NAICS code is 511210, Software Publishers. The size standard is $35.5 million.

FDA will evaluate quotations on a lowest price technically acceptable basis. FDA anticipates that this contract will be firm fixed price.

The following information is in the attached RFQ:
Description
Schedule of Pricing
Statement of Work
Inspection and Acceptance
Government Furnished Property
Period and Location of Performance
Contact Information
FAR and HHSAR Clauses and Provisions
Instructions to Offerors
Evaluation Factors

Please review the documents carefully. Questions regarding these documents should be submitted to the Contract Specialist, in writing via email to Jacob.ohatnick@fda.hhs.gov, no later than 3:00 PM Eastern Time, August 14, 2013. FDA will answer the questions it receives and send a complete list of questions and answers to all firms that received the RFQ by August 19, 2013. FDA will not answer questions asked via telephone or submitted to any FDA official other than the Contract Specialist. Final quotes are due to the Contract Specialist no later than 9:00 AM Eastern Time on August 26, 2013.